menu Menu Search
What are you looking for? close
RCVS Registered: 7025700
Run by a qualified team of Vets
First Class Delivery only £3.99
Next Day Delivery available
Senvelgo for Cats | Manage Cat Diabetes with Senvelgo for Cats

Senvelgo for Cats

Senvelgo for Cats - The Latest Treatment for Feline Diabetes

Senvelgo for Cats is a prescription oral liquid medication used to treat diabetes mellitus in cats. It contains the active substance velagliflozin, a selective sodium-glucose co-transporter 2 (SGLT2) inhibitor. Senvelgo is administered once daily by mouth and is designed to help reduce blood glucose levels in diabetic cats without the need for insulin injections.

Senvelgo is a significant advancement in the management of feline diabetes. It provides an alternative to traditional insulin therapy and may be suitable for certain cats diagnosed with stable diabetes mellitus. It is currently the only veterinary-approved SGLT2 inhibitor specifically formulated for cats.

Senvelgo is available by prescription only (POM-V) and must be used under the supervision of a veterinary surgeon. It is available as 12ml Senvelgo and 30ml Senvelgo

Diabetes Mellitus in Cats

Dia...

Senvelgo for Cats - The Latest Treatment for Feline Diabetes

Senvelgo for Cats is a prescription oral liquid medication used to treat diabetes mellitus in cats. It contains the active substance velagliflozin, a selective sodium-glucose co-transporter 2 (SGLT2) inhibitor. Senvelgo is administered once daily by mouth and is designed to help reduce blood glucose levels in diabetic cats without the need for insulin injections.

Senvelgo is a significant advancement in the management of feline diabetes. It provides an alternative to traditional insulin therapy and may be suitable for certain cats diagnosed with stable diabetes mellitus. It is currently the only veterinary-approved SGLT2 inhibitor specifically formulated for cats.

Senvelgo is available by prescription only (POM-V) and must be used under the supervision of a veterinary surgeon. It is available as 12ml Senvelgo and 30ml Senvelgo

Diabetes Mellitus in Cats

Diabetes mellitus is a chronic disease caused by a deficiency of insulin or an inability of the body to properly respond to insulin. In cats, this leads to persistently high blood glucose levels (hyperglycaemia), which can cause serious health problems if left untreated. Insulin is a hormone produced by the pancreas. It allows glucose from the blood to enter cells where it can be used for energy. When insulin is not produced in sufficient quantities, or when the body becomes resistant to it, glucose builds up in the bloodstream rather than being absorbed and used. This results in symptoms such as:

  • Increased thirst (polydipsia)
  • Increased urination (polyuria)
  • Weight loss despite a normal or increased appetite
  • Lethargy
  • Poor coat condition
  • Weakness in the hind limbs

Feline diabetes is most commonly seen in middle-aged to older cats and is often linked to obesity or underlying health conditions. Without appropriate treatment, diabetes can lead to life-threatening complications, including diabetic ketoacidosis (DKA).

Historically, most diabetic cats have been treated with daily insulin injections, alongside dietary management and regular blood glucose monitoring. While effective, insulin therapy requires a high level of commitment from the owner, including precise dosing, strict timing, and needle administration. For some owners, insulin injections may present challenges, and for some cats, consistent glucose control can remain difficult.

How Senvelgo Works

Senvelgo contains velagliflozin, a member of the SGLT2 inhibitor class of drugs. Unlike insulin, which lowers blood glucose by enhancing its uptake into cells, velagliflozin works by increasing the excretion of glucose in the urine. SGLT2 proteins are located in the kidneys and are responsible for reabsorbing glucose back into the bloodstream.

Velagliflozin selectively blocks these transporters, reducing the amount of glucose reabsorbed and increasing its elimination through urine. This helps reduce and stabilise blood glucose levels, even in cats with insulin resistance.

Senvelgo is administered once daily by mouth as a flavoured liquid, offering a non-invasive and needle-free treatment option. It does not require injection and does not depend on the cat’s insulin production, making it suitable for stable diabetic cats under veterinary supervision. The use of Senvelgo allows for a simplified treatment regimen and may improve both owner compliance and quality of life for diabetic cats who respond appropriately to the therapy.

Benefits of Senvelgo

  • Oral liquid formulation for easy, once-daily administration
  • Reduces blood glucose without requiring insulin injections
  • First licensed SGLT2 inhibitor for use in cats
  • Helps reduce polyuria, polydipsia, and weight loss associated with diabetes

Senvelgo is only indicated for use in stable diabetic cats and may not be suitable for cats with poorly regulated or unstable diabetes. It is important to note that it does not replace insulin in all cases, and its suitability should be determined by a vet based on blood glucose levels, general health, and other clinical factors.

Dosage and Administration

Senvelgo is supplied as a 4mg/ml oral solution, provided in a bottle with a dosing syringe for precise administration. The recommended starting dose is 1mg/kg bodyweight, given once daily.

Senvelgo should be given directly into the mouth using the syringe provided. It can be given with or without food. The bottle must be shaken well before use, and the dose should be measured accurately according to the veterinary prescription.

Monitoring is essential when starting treatment with Senvelgo. Vets will typically recommend follow-up visits to evaluate blood glucose levels, urine glucose, body weight, and overall response to treatment.

Cats receiving Senvelgo should have regular access to fresh water, as the increased loss of glucose through the urine may cause increased thirst and urination in the early stages.

Safety and Precautions

Senvelgo should only be used in cats that have been thoroughly evaluated by a vet. It is not suitable for use in the following situations:

  • Cats with type 1 diabetes or diabetic ketoacidosis (DKA)
  • Cats with severe kidney disease or dehydration
  • Cats that are pregnant or lactating
  • Kittens under 6 months of age

The most common side effects may include:

  • Increased urination (polyuria)
  • Increased thirst (polydipsia)
  • Mild weight loss
  • Occasional gastrointestinal upset

In rare cases, more serious adverse effects may occur, such as dehydration or urinary tract infections.

Cats should be monitored for changes in appetite, energy levels, and urination habits. Any signs of illness, vomiting, or collapse should be reported to the vet immediately. Senvelgo must be stored at room temperature and kept out of reach of children and other animals. Unused or expired medication can be returned to us for safe disposal.

Read more Read less
close
Senvelgo for Cats with Diabetes - 30ml

Senvelgo for Cats with Diabetes - 30ml

Senvelgo for Cats: The New Treatment for Feline Diabetes

Senvelgo for Cats is an oral solution designed to manage diabetes mellitus in cats. Formulated with velagliflozin, Senvelgo offers a targeted solution for maintaining glycaemic control, providing cat owners a streamlined and effective approach to caring for feline diabetes. This product is specifically indicated for cats who are newly diagnosed with diabetes mellitus and have not been previously treated with insulin.

Senvelgo’s daily oral administration is convenient for pet owners, available either by direct oral application or through a small amount of wet food. With careful weight-based dosing, Senvelgo allows precise control over the medication quantity administered. Additionally, it does not require refrigeration, making it a practical choice for pet care.

How Senvelgo Works

Senvelgo works by reducing high blood glucose levels, or hyperglycaemia, in cats with diabetes mellitus. The active ingredient, velagliflozin, is classified as a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It targets the kidney's function of glucose reabsorption, promoting the excretion of excess glucose through urine. By facilitating this process, Senvelgo helps to regulate blood glucose levels without relying on insulin injections, making it an alternative to insulin for cats not previously treated with insulin.

The action of Senvelgo is typically well-tolerated, leading to visible improvements in glycaemic control in some cats as early as the first week of treatment. This control minimises the risk of common symptoms associated with untreated or poorly managed diabetes in cats, such as excessive thirst, frequent urination, and weight loss. Moreover, the solution has a low risk of causing hypoglycaemia, a condition of dangerously low blood sugar levels, which is a concern with some diabetic treatments.

£162.88
Senvelgo for Cats with Diabetes - 12ml

Senvelgo for Cats with Diabetes - 12ml

Senvelgo 12ml Oral Solution for Cats is a prescription medication used for the treatment of diabetes mellitus in cats. It is a once-daily liquid formula that helps regulate blood glucose levels without the need for insulin injections.

Senvelgo is suitable for cats diagnosed with stable diabetes and is administered orally using the syringe provided. Diabetes mellitus is a chronic metabolic disorder commonly seen in older or overweight cats. It occurs when the body is either unable to produce enough insulin or cannot effectively use the insulin it does produce. Insulin is a hormone necessary for the body to regulate blood sugar (glucose) levels. Without sufficient insulin action, glucose cannot enter the cells properly and begins to accumulate in the bloodstream. This leads to a variety of health issues if not managed appropriately.

Senvelgo contains the active ingredient velagliflozin, a selective sodium-glucose co-transporter 2 (SGLT2) inhibitor. It works by increasing the amount of glucose excreted in the urine, thereby lowering blood sugar levels. By helping to reduce hyperglycaemia without directly increasing insulin levels, Senvelgo provides an alternative approach to diabetes management in cats.

Senvelgo is not a form of insulin and does not replace insulin in all cases. It is designed for use in cats who are able to maintain stable blood sugar levels without insulin or as advised by a veterinary professional. Its once-daily oral administration makes it a convenient option for pet owners who may find injections challenging or stressful for their cat.

Each 12ml bottle of Senvelgo is supplied with a dosing syringe that allows for accurate administration. The dosage is determined by a veterinarian based on your cat’s weight and specific condition. It is important to follow the dosing instructions carefully to ensure effective management of the disease. Senvelgo should be given directly into the cat’s mouth and not mixed with food or water.

VETERINARY PRESCRIPTION REQUIRED

£78.28